Cargando…
Immunotherapeutic advances in gastrointestinal malignancies
Cancer is an important global issue with increasing incidence and mortality, placing a substantial burden on the healthcare system. Colorectal cancer is the third most common cancer diagnosed among men and women in US. It is estimated that in 2018 there will be 319,160 new diagnosis and 160,820 deat...
Autores principales: | Rao, Devika, Parakrama, Ruwan, Augustine, Titto, Liu, Qiang, Goel, Sanjay, Maitra, Radhashree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363766/ https://www.ncbi.nlm.nih.gov/pubmed/30729176 http://dx.doi.org/10.1038/s41698-018-0076-8 |
Ejemplares similares
-
Immune characterization of metastatic colorectal cancer patients post reovirus administration
por: Parakrama, Ruwan, et al.
Publicado: (2020) -
Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
por: Maitra, Radhashree, et al.
Publicado: (2017) -
Telomere length regulation through epidermal growth factor receptor signaling in cancer
por: Augustine, Titto, et al.
Publicado: (2017) -
Molecular Tools for Metastatic Colorectal Cancer Characterization
por: Maitra, Radhashree, et al.
Publicado: (2020) -
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer
por: Maitra, Radhashree, et al.
Publicado: (2019)